NO174766C - Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem - Google Patents

Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem

Info

Publication number
NO174766C
NO174766C NO883838A NO883838A NO174766C NO 174766 C NO174766 C NO 174766C NO 883838 A NO883838 A NO 883838A NO 883838 A NO883838 A NO 883838A NO 174766 C NO174766 C NO 174766C
Authority
NO
Norway
Prior art keywords
diltiazem
preparation
dosing unit
controlled administration
administration
Prior art date
Application number
NO883838A
Other languages
English (en)
Norwegian (no)
Other versions
NO883838D0 (no
NO174766B (no
NO883838L (no
Inventor
George V Guittard
Patrick S L Wong
Felix Theeuwes
Richard Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO883838D0 publication Critical patent/NO883838D0/no
Publication of NO883838L publication Critical patent/NO883838L/no
Publication of NO174766B publication Critical patent/NO174766B/no
Publication of NO174766C publication Critical patent/NO174766C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO883838A 1988-06-02 1988-08-29 Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem NO174766C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,519 US4859470A (en) 1988-06-02 1988-06-02 Dosage form for delivering diltiazem

Publications (4)

Publication Number Publication Date
NO883838D0 NO883838D0 (no) 1988-08-29
NO883838L NO883838L (no) 1989-12-04
NO174766B NO174766B (no) 1994-03-28
NO174766C true NO174766C (no) 1994-07-06

Family

ID=22746162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883838A NO174766C (no) 1988-06-02 1988-08-29 Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem

Country Status (25)

Country Link
US (1) US4859470A (fr)
JP (1) JP2590226B2 (fr)
KR (1) KR960006062B1 (fr)
AR (1) AR241635A1 (fr)
AT (1) AT394311B (fr)
AU (1) AU612398B2 (fr)
BE (1) BE1001935A3 (fr)
CA (1) CA1311687C (fr)
CH (1) CH675208A5 (fr)
DE (1) DE3829941C2 (fr)
DK (1) DK175396B1 (fr)
ES (1) ES2008813A6 (fr)
FI (1) FI92553C (fr)
FR (1) FR2632306B1 (fr)
GB (1) GB2219205B (fr)
GR (1) GR1000197B (fr)
IE (1) IE61861B1 (fr)
IT (1) IT1223799B (fr)
LU (1) LU87327A1 (fr)
MX (1) MX174157B (fr)
NL (1) NL194747C (fr)
NO (1) NO174766C (fr)
PT (1) PT88405B (fr)
SE (1) SE503508C2 (fr)
ZA (1) ZA886436B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
HU229295B1 (en) * 1999-08-04 2013-10-28 Astellas Pharma Inc Stable medicinal compositions for oral use
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
CN101849921A (zh) 2004-08-13 2010-10-06 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂
JP4971159B2 (ja) 2004-08-13 2012-07-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその薬学的に許容しうる塩を含有する徐放性ペレット製剤、その製法及び使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
ATE75394T1 (de) * 1986-11-14 1992-05-15 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.

Also Published As

Publication number Publication date
GB8820461D0 (en) 1988-09-28
AU2152788A (en) 1989-12-07
KR960006062B1 (ko) 1996-05-08
DE3829941A1 (de) 1989-12-14
MX174157B (es) 1994-04-25
DE3829941C2 (de) 1997-07-03
CH675208A5 (fr) 1990-09-14
KR900000076A (ko) 1990-01-30
GB2219205B (en) 1992-07-15
AU612398B2 (en) 1991-07-11
ATA214588A (de) 1991-09-15
FI92553B (fi) 1994-08-31
SE8803085L (sv) 1989-12-03
DK175396B1 (da) 2004-09-27
IT1223799B (it) 1990-09-29
JPH01313432A (ja) 1989-12-18
NO883838D0 (no) 1988-08-29
NL8802181A (nl) 1990-01-02
AR241635A1 (es) 1992-10-30
GR880100574A (en) 1990-05-11
FR2632306A1 (fr) 1989-12-08
JP2590226B2 (ja) 1997-03-12
PT88405B (pt) 1995-07-18
CA1311687C (fr) 1992-12-22
NL194747B (nl) 2002-10-01
US4859470A (en) 1989-08-22
GB2219205A (en) 1989-12-06
IT8867791A0 (it) 1988-09-02
NL194747C (nl) 2003-02-04
AT394311B (de) 1992-03-10
FI884057A (fi) 1989-12-03
SE503508C2 (sv) 1996-06-24
PT88405A (pt) 1990-06-29
DK485688A (da) 1989-12-03
NO174766B (no) 1994-03-28
BE1001935A3 (fr) 1990-04-17
FI92553C (fi) 1994-12-12
IE882642L (en) 1989-12-02
SE8803085D0 (sv) 1988-09-02
NO883838L (no) 1989-12-04
LU87327A1 (fr) 1989-03-08
FR2632306B1 (fr) 1990-11-16
FI884057A0 (fi) 1988-09-02
IE61861B1 (en) 1994-11-30
ES2008813A6 (es) 1989-08-01
DK485688D0 (da) 1988-09-01
GR1000197B (el) 1992-03-20
ZA886436B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI98046B (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO863670L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
FI885884A0 (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI891021A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
FI871492A (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
NO174766C (no) Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
NO894167L (no) Fremgangsmaate for fremstilling av en fylt vann-tverrbindbar silankopolymersammensetning.
NO934897D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO890540L (no) Fremgangsmaate for fremstilling av et proteinholdig naeringsmiddel.
FI104171B (fi) Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
FI93107B (fi) Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
FI892144A (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
NO177750C (no) Analogifremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt
NO874539D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Legal Events

Date Code Title Description
MK1K Patent expired